A method for al of a volatile anesthetic agent from a breathing gas in a respirating apparatus includes the steps of leading at least a portion of the breathing gas through a portion of a line system in which the portion of the line system has a filter therein, cooling the breathing gas to a temperature below a temperature of the boiling point of the anesthetic agent when the breathing gas passes through the filter so as to condense the anesthetic agent out of the breathing gas, warming the breathing gas after the anesthetic agent is condensed, and leading the warmed breathing gas out of the portion of the line system back into the line system. The filter has activated carbon therein.

A method for maintaining ventilation during an oxygen flush in an anaesthetic breathing apparatus (2) is disclosed. The breathing apparatus (2) comprises a breathing circuit (3), a fresh gas section (5), and a ventilator section (7). The fresh gas section (5) comprises an oxygen supply (12), and the ventilator section (7) comprises an expiratory pressure control valve (21). The method (100) comprises steps of: starting a continuous flow of oxygen from the oxygen supply (12) into the breathing circuit (3) interrupting an ongoing ventilation in order to activate the oxygen flush; maintaining the continuous flow of oxygen; and cycling the expiratory pressure control valve (21) between an upper pressure level setting to provide an inspiratory phase of a breathing cycle and a lower pressure level setting to provide an expiratory phase of the breathing cycle.

The subject matter described herein includes a mask for use in providing oxygen or nebulized medicaments. The mask includes at least two straps and a plurality of apertures defined along two sides of the mask. The apertures are configured for receiving the at least two straps at more than two positions along a length of the mask. The mask includes at least one exhalation port and an inhalation port for receiving the oxygen or nebulized medicaments. In operation an oxygen delivery tube and reservoir bag are connected to the inhalation port.

This invention relates to a portable rebreathing system, said portable rebreathing system comprising a breathing mask (4), a carbon dioxide scrubber (3), a counter lung (2), ambient air ports and an oxygen supply port (5), with the breathing mask (4) connectable with a mask connector to a common valve housing (X) containing said carbon dioxide scrubber (3), ambient air port and oxygen supply port, and with the counter lung (2) connectable with a counter lung connector to the common housing.

The main features of the invention are two one way check valves close to breathing mask connects to an exhale passage and an inhale passage respectively in a rebreathing mode. A small common valve housing (X) with control valves open a rebreathing circuit to the counter lung when pressure from an oxygen supply source is applied on the control valves, and when pressure drops open a breathing circuit to ambient air. Supply of fresh oxygen is added into the rebreathing circuit directly upstream of or at the inhale check valve.

This design utilizes the oxygen supply efficiently with minimum oxygen losses.

The subject matter of the application is a device for adjustment and/or regulation of the CO.sub.2, carbon dioxide content of the inhaled air. Device based on the invention where a CO.sub.2 vessel 30 is connected to the CO.sub.2 input aperture 22, a measuring tool 15 determining the CO.sub.2 content of the exhaled air is connected to the exhaled air pipe 11, the output aperture of the measuring tool 15 is connected to the input aperture of a control unit 50, and the output aperture of the control unit 50 is connected to the valve 28 adjusting the blending rate of blending vessel 20 and so adjusting the CO.sub.2 content of the inhaled air.

An air conditioning assembly for an environmental chamber includes an air handling unit for supplying air to the environmental chamber. A plurality of ducts in fluid communication with the air handing unit and in fluid communication with the environmental chamber are configured to draw air from one side of the environmental chamber through at least one outlet vent, and to blow air into an opposite side of the environmental chamber through at least one equal but opposite inlet vent. At least one air conditioning means in fluid communication with the at least one air handling unit is configured to condition the air flow passing through the air handling unit. The at least one air conditioning means includes an altitude simulator for changing the oxygen content of the air flow. In use, the air conditioning assembly is configured to create substantially laminar air flow throughout the environmental chamber.

A device for capturing momentarily an exhaled breath of a COVID 19 patient containing active SARS-CoV-2 virions within an accessible compartment of said device and converting said active SARS-CoV-2 virions into far-UVC inactivated SARS-CoV-2 virions by exposure to an activated 222 nm far-UVC lamp mounted in said accessible compartment and with the next inhaled breath of said COVID 19 patient said far-UVC inactivated SARS-CoV-2 virions are positioned within the respiratory system ready to be captured by an antigen-presenting cells such as the Dendritic cells (DCs) which are antigen-presenting cells that capture, process, and present antigens to lymphocytes to initiate and regulate the adaptive immune response. Said far-UVC inactivated SARS-CoV-2 virions can be collected from said accessible compartment of said device and processed into viable vaccine that can be administered to front-line workers.

An anesthesia machine, an anesthetic output concentration monitoring method, system, a device, and a storage medium are disclosed. The method includes respectively monitoring a flow of a fresh gas flowing into a breathing circuit and a flow of an inhaled gas of an anesthetized object. The method further includes when the inhaled gas flow is greater than a fresh gas flow, respectively monitoring a concentration of anesthetic in the inhaled gas and an exhaled gas of the anesthetized object. The method also includes using the exhaled gas anesthetic concentration and a concentration of carbon dioxide in the exhaled gas to calculate a concentration of anesthetic in a gas, reflowing into an inspiratory branch, in the exhaled gas, thereby obtaining a re-inhaled gas anesthetic concentration. The method additionally includes using the fresh gas flow, the inhaled gas flow, the inhaled gas anesthetic concentration, and the re-inhaled gas anesthetic concentration to calculate a concentration of output anesthetic of an anesthetic output device, thereby obtaining an anesthetic output concentration.

Provided herein are methods of treatment, including methods of treating subjects having or at risk of having or having a viral infection, and specifically a SARS-CoV-2 viral infection. The methods provided include the administration of 4-methylumbelliferone (4-MU), palmitoylethanolamide (PEA), resveratrol, fisetin, H.sub.2, nebulized hyaluronidase or combinations thereof. Also provided herein are a respiratory assistance device, methods of generating a customized respiratory assistance device, methods of treating a coronavirus infection, and methods of inhibiting a coronavirus infectivity, virulence and/or spread.

The invention relates to a breathing device (1), comprising a mouthpiece (2) forming a breathing channel to form a connection between a first (3) end and a second (4) end of the mouthpiece (2). The first (3) end is configured for a user breathing into the mouthpiece through a breathing opening (5). An at least partly flexible rebreathing air chamber (6) is arranged in fluid communication with the second (4) end of the mouthpiece, thereby being in fluid connection with the breathing channel through the second end of the mouthpiece (2). The rebreathing air chamber is formed by at least partly flexible wall section(s). A wall member (7) is arranged at the second (4) end of the mouthpiece and/or attached to the rebreathing air chamber (6). The wall member (7) comprises one or more through-going openings (8) provided in the wall member (7) and/or in the breathing channel, allowing fluid communication between the rebreathing air chamber (6) and the surrounding atmosphere.